Journal Article
. 2001 Dec; 7(12):4122-9.

Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics

B Naume 1 E Borgen  G Kvalheim  R Kåresen  H Qvist  T Sauer  T Kumar  J M Nesland  
Affiliations
  • PMID: 11751511
  •     22 citations

Abstract

Unlabelled: PURPOSE/EXPERIMENTAL DESIGN: The importance of detection of disseminated isolated tumor cells (ITCs) in bone marrow (BM) is still not settled. BM aspirates from 920 patients with primary breast cancer were analyzed for tumor cells by standardized direct immunocytochemical analysis (ICC) of 2 x 10(6) mononuclear cells (MNCs) using anticytokeratin monoclonal antibody (AE1/AE3). Samples (637) were analyzed by negative immunomagnetic enrichment (IMS) followed by ICC (10 x 10(6) MNCs). Analyses of the primary tumor specimens have been performed, including histomorphology, tumor-node-metastasis (TNM) staging, grading, and immunohistochemical analyses.

Results: Of the patients with infiltrating carcinoma, 63% were node negative (N0) and 33%, node positive (N+). The results show the presence of tumor cells in 13.4% of the evaluable patients after direct ICC analysis. The presence of tumor cells correlated to the nodal- and tumor stage, showing BM positivity in 9.9% of the N0 cases and 20.6% in the N+ group (P < 0.0005), 11.2% of the stage T(1) were positive, and 15.0% and 22.6% were positive in the T(2) and T(3/4) groups, respectively (P = 0.013). No correlation between detection of ITC and detection of p53 and cathepsin D expression was found. Vascular invasion and c-erbB2 expression were associated with ITCs in BM (P = 0.045 and P = 0.024, respectively). Node-negative patients with estrogen receptor (ER)+ and/or progesterone receptor (PgR)+ tumors had lower frequency of ITCs than ER-/PgR- (P = 0.004). The use of negative IMS increased the frequency of positive BM by 63% (P < 0.0005).

Conclusions: The direct ICC detection of ITCs in BM correlated with primary tumor stage, nodal stage, vascular invasion, c-erbB2 expression, and ER/PgR status. Analysis of larger BM samples by negative IMS resulted in increased number of ITC-positive patients.

Other Links

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
Valérie Choesmel, Jean-Yves Pierga, +4 authors, Nathalie Blin.
Breast Cancer Res, 2004 Aug 21; 6(5). PMID: 15318937    Free PMC article.
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
Neslihan Cabioglu, Aysegul Sahin, +8 authors, Janet E Price.
Clin Exp Metastasis, 2005 Sep 01; 22(1). PMID: 16132577
Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
Christian Schindlbeck, Theresa Kampik, +5 authors, Klaus Friese.
Breast Cancer Res, 2006 Feb 07; 7(6). PMID: 16457698    Free PMC article.
Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.
Abhik Bandyopadhyay, Long Wang, Shiau Hui Chin, Lu-Zhe Sun.
Neoplasia, 2007 Mar 16; 9(2). PMID: 17356707    Free PMC article.
Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues.
A Vincent-Salomon, F C Bidard, J Y Pierga.
J Clin Pathol, 2007 Nov 27; 61(5). PMID: 18037661    Free PMC article.
Review.
Inhibition of osteolytic bone metastasis by unfractionated heparin.
Colin K Yee, Martin Butcher, +2 authors, Stephen G Shaughnessy.
Clin Exp Metastasis, 2008 Sep 25; 25(8). PMID: 18814041
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.
Bjørn Naume, Xi Zhao, +10 authors, Therese Sørlie.
Mol Oncol, 2007 Sep 01; 1(2). PMID: 19383292    Free PMC article.
Cytokeratin-positive cells in the bone marrow of breast cancer patients and noncancer donors.
David N Krag, Roberto Kusminsky, +9 authors, Patricia Amarante.
Appl Immunohistochem Mol Morphol, 2009 May 07; 17(5). PMID: 19417625    Free PMC article.
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors.
Espen Enerly, Israel Steinfeld, +14 authors, Anne-Lise Børresen-Dale.
PLoS One, 2011 Mar 03; 6(2). PMID: 21364938    Free PMC article.
Highly Cited.
The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
Timothy J Molloy, Astrid J Bosma, +6 authors, Bjørn Naume.
Breast Cancer Res, 2011 Jun 16; 13(3). PMID: 21672237    Free PMC article.
Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.
Montserrat Solá, Mireia Margelí, +6 authors, Manuel Fraile.
BMC Cancer, 2011 Jun 18; 11. PMID: 21679400    Free PMC article.
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Randi R Mathiesen, Elin Borgen, +10 authors, Bjørn Naume.
Breast Cancer Res, 2012 Aug 15; 14(4). PMID: 22889108    Free PMC article.
Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.
Miriam Ragle Aure, Israel Steinfeld, +9 authors, Zohar Yakhini.
PLoS One, 2013 Feb 06; 8(1). PMID: 23382830    Free PMC article.
The clinical impact of mean vessel size and solidity in breast carcinoma patients.
Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, +4 authors, Dag Rune Olsen.
PLoS One, 2013 Oct 23; 8(10). PMID: 24146798    Free PMC article.
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors.
Miriam Ragle Aure, Suvi-Katri Leivonen, +16 authors, Vessela N Kristensen.
Genome Biol, 2013 Nov 22; 14(11). PMID: 24257477    Free PMC article.
Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo.
S Winsel, J Mäki-Jouppila, +8 authors, M J Kallio.
Br J Cancer, 2014 Oct 01; 111(11). PMID: 25268374    Free PMC article.
MicroRNA let-7b regulates genomic balance by targeting Aurora B kinase.
Jenni Heidi Eveliina Mäki-Jouppila, Sofia Pruikkonen, +6 authors, Marko Johannes Kallio.
Mol Oncol, 2015 Feb 17; 9(6). PMID: 25682900    Free PMC article.
Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.
Vilde D Haakensen, Israel Steinfeld, +6 authors, Zohar Yakhini.
Mol Oncol, 2015 Sep 01; 10(1). PMID: 26321095    Free PMC article.
Isolating Sperm from Cell Mixtures Using Magnetic Beads Coupled with an Anti-PH-20 Antibody for Forensic DNA Analysis.
Xing-Chun Zhao, Le Wang, +3 authors, Jian Ye.
PLoS One, 2016 Jul 22; 11(7). PMID: 27442128    Free PMC article.
Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity.
Sofia Pruikkonen, Marko J Kallio.
Br J Cancer, 2017 Apr 28; 116(11). PMID: 28449010    Free PMC article.
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Hege O Ohnstad, Elin Borgen, +11 authors, Bjørn Naume.
Breast Cancer Res, 2017 Nov 16; 19(1). PMID: 29137653    Free PMC article.
Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.
Stephanie Strobl, Kerstin Wimmer, +4 authors, Michael Gnant.
Curr Treat Options Oncol, 2018 Mar 13; 19(4). PMID: 29527635
Review.